Pharmacokinetics, safety, and tolerability of intramuscular ziprasidone in healthy volunteers.

@article{Miceli2005PharmacokineticsSA,
  title={Pharmacokinetics, safety, and tolerability of intramuscular ziprasidone in healthy volunteers.},
  author={Jeffrey J Miceli and Keith D. Wilner and Suzanne K. Swan and Thomas G. Tensfeldt},
  journal={Journal of clinical pharmacology},
  year={2005},
  volume={45 6},
  pages={620-30}
}
Little has been published regarding the pharmacokinetics of the intramuscular (IM) formulation of Ziprasidone. The authors report results from 2 early phase I studies in healthy volunteers: a trial of single 5-, 10-, or 20-mg IM doses of ziprasidone in 24 subjects and an open-label 3-way crossover trial of 5-mg intravenous (IV), 5-mg IM, and 20-mg oral… CONTINUE READING